Middle East BRIC Diabetes Care Devices Market Size Share Growth Drivers Trends Opportunities & Forecast 2025–2030

Middle East BRIC diabetes care devices market grows with tech advancements and rising diabetes prevalence.

Region:Middle East

Author(s):Dev

Product Code:KRAC1186

Pages:98

Published On:December 2025

About the Report

Base Year 2024

Middle East BRIC Diabetes Care Devices Market Overview

  • The Middle East BRIC Diabetes Care Devices Market is valued at USD 2.5 billion, based on recent analysis. Growth is propelled by rising diabetes prevalence driven by lifestyle changes and urbanization across the region, along with technological advancements such as continuous glucose monitoring systems gaining adoption to improve patient outcomes. Increased healthcare spending and awareness of chronic disease management further underpin this expansion.
  • Key players in this market include Saudi Arabia, the UAE, Iran, Egypt, and South Africa, benefiting from high disease burden and expanding infrastructure. These dynamics are reinforced by major players such as Abbott, Medtronic, Roche, Dexcom, and Novo Nordisk, which lead through innovation in areas like insulin delivery and monitoring systems and by expanding distribution partnerships and regional hubs with local firms.
  • In 2024, Saudi Arabia's Vision 2030 initiative is fostering domestic assembly of insulin pens, expanding digital health, and enhancing reimbursement for continuous glucose monitoring, bolstering clinician confidence and market accessibility.
Middle East BRIC Diabetes Care Devices Market Size

Middle East BRIC Diabetes Care Devices Market Segmentation

By Device Type:The market for diabetes care devices is segmented into various device types, including Blood Glucose Monitors, Insulin Delivery Devices, Continuous Glucose Monitoring Systems, Diabetes Management Software, and Others. Among these, Blood Glucose Monitors are the most widely used due to their essential role in daily diabetes management. The increasing prevalence of diabetes has led to a surge in demand for these devices, as they provide immediate feedback to patients regarding their glucose levels, thus facilitating better disease management.

Middle East BRIC Diabetes Care Devices Market segmentation by Device Type.

By End-User:The diabetes care devices market is also segmented by end-user, which includes Hospitals, Home Care Settings, Diabetes Clinics, and Others. Hospitals are the leading end-users due to their capacity to provide comprehensive diabetes management services, including access to advanced technologies and healthcare professionals. The growing number of diabetes cases has led to increased hospital admissions, further driving the demand for diabetes care devices in these settings.

Middle East BRIC Diabetes Care Devices Market segmentation by End-User.

Middle East BRIC Diabetes Care Devices Market Competitive Landscape

The Middle East BRIC Diabetes Care Devices Market is characterized by a dynamic mix of regional and international players. Leading participants such as Abbott Laboratories, Medtronic, Roche Diabetes Care, Johnson & Johnson, Novo Nordisk, Sanofi, Bayer AG, Dexcom, Ascensia Diabetes Care, Insulet Corporation, Ypsomed, B. Braun Melsungen AG, Acon Laboratories, LifeScan, Glooko contribute to innovation, geographic expansion, and service delivery in this space.

Abbott Laboratories

1888

Abbott Park, Illinois, USA

Medtronic

1949

Dublin, Ireland

Roche Diabetes Care

1896

Basel, Switzerland

Johnson & Johnson

1886

New Brunswick, New Jersey, USA

Novo Nordisk

1923

Bagsværd, Denmark

Company

Establishment Year

Headquarters

Group Size (Large, Medium, or Small as per industry convention)

Revenue Growth Rate

Market Penetration Rate

Customer Retention Rate

Pricing Strategy

Product Innovation Rate

Middle East BRIC Diabetes Care Devices Market Industry Analysis

Growth Drivers

  • Healthcare Technology Investment:In future, venture capital investment in Middle East healthcare technology reached USD 3.2 billion. This surge in funding is driving the adoption of digital health solutions, including telemedicine and remote monitoring, which are crucial for diabetes care devices. The increased investment supports the development of innovative technologies that enhance patient management and improve health outcomes, thereby expanding the diabetes care device market significantly.
  • Healthcare Expenditure by GCC Governments:In future, GCC countries, including Saudi Arabia and the UAE, invested approximately USD 93.2 billion in healthcare. Saudi Arabia alone allocated SAR 214 billion (around USD 57 billion) for healthcare initiatives. This substantial funding facilitates the procurement and deployment of diabetes care devices, ensuring that public health initiatives can effectively address the rising diabetes prevalence in the region.
  • Digital Health Market Size:The Middle East digital health market was valued at USD 5.96 billion in future, with diabetes applications holding the largest revenue share. This growth reflects the increasing demand for integrated diabetes management solutions, including mobile health applications and connected devices. The expansion of this market segment is pivotal for enhancing diabetes care and improving patient outcomes across the region.

Market Challenges

  • Skills Shortage in Health Technology:The Middle East faces a significant shortage of professionals trained in advanced health technologies, including AI and data science. This skills gap limits the effective implementation and maintenance of sophisticated diabetes care devices and digital health systems. As healthcare technology evolves, the lack of qualified personnel poses a substantial barrier to optimizing diabetes management solutions in the region.
  • EHR Adoption Gap in Egypt:As of future, only 314 hospitals in Egypt had implemented electronic health record (EHR) systems. This limited digital infrastructure hampers the integration of diabetes device data into healthcare workflows, affecting the quality of care. The slow adoption of EHRs in certain Middle Eastern countries presents a significant challenge to the effective management of diabetes and the utilization of care devices.

Middle East BRIC Diabetes Care Devices Market Future Outlook

The future of the Middle East BRIC diabetes care devices market is poised for significant transformation, driven by advancements in technology and increasing healthcare investments. The integration of AI and telehealth solutions will enhance diabetes management, enabling personalized care and improved patient outcomes. Additionally, the expansion of smart hospitals and IoT devices will facilitate better connectivity and data sharing, further optimizing diabetes care. These trends indicate a promising landscape for innovation and growth in the diabetes care sector.

Market Opportunities

  • Underserved Digital Health Segments:The diabetes application segment within the USD 5.96 billion digital health market represents a significant opportunity for growth. Expanding device integration for diabetes management, such as glucose monitors and wearables, can capitalize on this dominant segment, enhancing patient care and driving market expansion.
  • Export Potential via Regional Innovation Hubs:The launch of Abu Dhabi's global AI & Healthcare Innovation Hub in future aims to commercialize healthcare solutions across the Middle East, Turkey, and Africa. This initiative presents an opportunity for the development and export of innovative diabetes device solutions, potentially increasing market reach and revenue.

Scope of the Report

SegmentSub-Segments
By Device Type

Blood Glucose Monitors

Insulin Delivery Devices

Continuous Glucose Monitoring Systems

Diabetes Management Software

Others

By End-User

Hospitals

Home Care Settings

Diabetes Clinics

Others

By Distribution Channel

Online Retail

Pharmacies

Hospitals

Direct Sales

Others

By Region

GCC Countries

Levant Region

North Africa

Others

By Age Group

Children

Adults

Elderly

Others

By Income Level

Low-Income

Middle-Income

High-Income

Others

By Technology Adoption

Traditional Devices

Smart Devices

Wearable Technology

Others

Key Target Audience

Investors and Venture Capitalist Firms

Government and Regulatory Bodies (e.g., Ministry of Health, Food and Drug Administration)

Manufacturers and Producers

Distributors and Retailers

Healthcare Providers and Hospitals

Technology Providers

Industry Associations (e.g., Diabetes Associations)

Financial Institutions

Players Mentioned in the Report:

Abbott Laboratories

Medtronic

Roche Diabetes Care

Johnson & Johnson

Novo Nordisk

Sanofi

Bayer AG

Dexcom

Ascensia Diabetes Care

Insulet Corporation

Ypsomed

B. Braun Melsungen AG

Acon Laboratories

LifeScan

Glooko

Table of Contents

Market Assessment Phase

1. Executive Summary and Approach


2. Middle East BRIC Diabetes Care Devices Market Overview

2.1 Key Insights and Strategic Recommendations

2.2 Middle East BRIC Diabetes Care Devices Market Overview

2.3 Definition and Scope

2.4 Evolution of Market Ecosystem

2.5 Timeline of Key Regulatory Milestones

2.6 Value Chain & Stakeholder Mapping

2.7 Business Cycle Analysis

2.8 Policy & Incentive Landscape


3. Middle East BRIC Diabetes Care Devices Market Analysis

3.1 Growth Drivers

3.1.1 Increasing prevalence of diabetes
3.1.2 Advancements in diabetes care technology
3.1.3 Rising healthcare expenditure
3.1.4 Growing awareness about diabetes management

3.2 Market Challenges

3.2.1 High cost of diabetes care devices
3.2.2 Limited access to healthcare facilities
3.2.3 Regulatory hurdles
3.2.4 Lack of trained healthcare professionals

3.3 Market Opportunities

3.3.1 Expansion of telemedicine services
3.3.2 Development of affordable diabetes care solutions
3.3.3 Increasing investment in healthcare infrastructure
3.3.4 Collaborations with tech companies for innovative solutions

3.4 Market Trends

3.4.1 Shift towards personalized diabetes management
3.4.2 Integration of AI in diabetes care devices
3.4.3 Growth of mobile health applications
3.4.4 Emphasis on preventive healthcare

3.5 Government Regulation

3.5.1 Stricter quality control measures
3.5.2 Incentives for local manufacturing
3.5.3 Guidelines for diabetes management
3.5.4 Policies promoting health education

4. SWOT Analysis


5. Stakeholder Analysis


6. Porter's Five Forces Analysis


7. Middle East BRIC Diabetes Care Devices Market Market Size, 2019-2024

7.1 By Value

7.2 By Volume

7.3 By Average Selling Price


8. Middle East BRIC Diabetes Care Devices Market Segmentation

8.1 By Device Type

8.1.1 Blood Glucose Monitors
8.1.2 Insulin Delivery Devices
8.1.3 Continuous Glucose Monitoring Systems
8.1.4 Diabetes Management Software
8.1.5 Others

8.2 By End-User

8.2.1 Hospitals
8.2.2 Home Care Settings
8.2.3 Diabetes Clinics
8.2.4 Others

8.3 By Distribution Channel

8.3.1 Online Retail
8.3.2 Pharmacies
8.3.3 Hospitals
8.3.4 Direct Sales
8.3.5 Others

8.4 By Region

8.4.1 GCC Countries
8.4.2 Levant Region
8.4.3 North Africa
8.4.4 Others

8.5 By Age Group

8.5.1 Children
8.5.2 Adults
8.5.3 Elderly
8.5.4 Others

8.6 By Income Level

8.6.1 Low-Income
8.6.2 Middle-Income
8.6.3 High-Income
8.6.4 Others

8.7 By Technology Adoption

8.7.1 Traditional Devices
8.7.2 Smart Devices
8.7.3 Wearable Technology
8.7.4 Others

9. Middle East BRIC Diabetes Care Devices Market Competitive Analysis

9.1 Market Share of Key Players

9.2 Cross Comparison of Key Players

9.2.1 Company Name
9.2.2 Group Size (Large, Medium, or Small as per industry convention)
9.2.3 Revenue Growth Rate
9.2.4 Market Penetration Rate
9.2.5 Customer Retention Rate
9.2.6 Pricing Strategy
9.2.7 Product Innovation Rate
9.2.8 Distribution Network Efficiency
9.2.9 Brand Recognition Score
9.2.10 Customer Satisfaction Index

9.3 SWOT Analysis of Top Players

9.4 Pricing Analysis

9.5 Detailed Profile of Major Companies

9.5.1 Abbott Laboratories
9.5.2 Medtronic
9.5.3 Roche Diabetes Care
9.5.4 Johnson & Johnson
9.5.5 Novo Nordisk
9.5.6 Sanofi
9.5.7 Bayer AG
9.5.8 Dexcom
9.5.9 Ascensia Diabetes Care
9.5.10 Insulet Corporation
9.5.11 Ypsomed
9.5.12 B. Braun Melsungen AG
9.5.13 Acon Laboratories
9.5.14 LifeScan
9.5.15 Glooko

10. Middle East BRIC Diabetes Care Devices Market End-User Analysis

10.1 Procurement Behavior of Key Ministries

10.1.1 Budget Allocation for Diabetes Care
10.1.2 Procurement Processes
10.1.3 Supplier Selection Criteria
10.1.4 Contract Management Practices

10.2 Corporate Spend on Infrastructure & Energy

10.2.1 Investment in Healthcare Facilities
10.2.2 Spending on Technology Upgrades
10.2.3 Budget for Training Healthcare Professionals
10.2.4 Others

10.3 Pain Point Analysis by End-User Category

10.3.1 Challenges Faced by Hospitals
10.3.2 Issues in Home Care Settings
10.3.3 Barriers in Diabetes Clinics
10.3.4 Others

10.4 User Readiness for Adoption

10.4.1 Awareness Levels
10.4.2 Training Needs
10.4.3 Technology Acceptance
10.4.4 Others

10.5 Post-Deployment ROI and Use Case Expansion

10.5.1 Measurement of ROI
10.5.2 Expansion Opportunities
10.5.3 User Feedback Mechanisms
10.5.4 Others

11. Middle East BRIC Diabetes Care Devices Market Future Size, 2025-2030

11.1 By Value

11.2 By Volume

11.3 By Average Selling Price


Go-To-Market Strategy Phase

1. Whitespace Analysis + Business Model Canvas

1.1 Market Gaps Identification

1.2 Business Model Development


2. Marketing and Positioning Recommendations

2.1 Branding Strategies

2.2 Product USPs


3. Distribution Plan

3.1 Urban Retail vs Rural NGO Tie-ups


4. Channel & Pricing Gaps

4.1 Underserved Routes

4.2 Pricing Bands


5. Unmet Demand & Latent Needs

5.1 Category Gaps

5.2 Consumer Segments


6. Customer Relationship

6.1 Loyalty Programs

6.2 After-sales Service


7. Value Proposition

7.1 Sustainability

7.2 Integrated Supply Chains


8. Key Activities

8.1 Regulatory Compliance

8.2 Branding

8.3 Distribution Setup


9. Entry Strategy Evaluation

9.1 Domestic Market Entry Strategy

9.1.1 Product Mix
9.1.2 Pricing Band
9.1.3 Packaging

9.2 Export Entry Strategy

9.2.1 Target Countries
9.2.2 Compliance Roadmap

10. Entry Mode Assessment

10.1 JV

10.2 Greenfield

10.3 M&A

10.4 Distributor Model


11. Capital and Timeline Estimation

11.1 Capital Requirements

11.2 Timelines


12. Control vs Risk Trade-Off

12.1 Ownership vs Partnerships


13. Profitability Outlook

13.1 Breakeven Analysis

13.2 Long-term Sustainability


14. Potential Partner List

14.1 Distributors

14.2 JVs

14.3 Acquisition Targets


15. Execution Roadmap

15.1 Phased Plan for Market Entry

15.1.1 Market Setup
15.1.2 Market Entry
15.1.3 Growth Acceleration
15.1.4 Scale & Stabilize

15.2 Key Activities and Milestones

15.2.1 Milestone Planning
15.2.2 Activity Tracking

Research Methodology

ApproachModellingSample

Phase 1: Approach1

Desk Research

  • Analysis of market reports from healthcare organizations and diabetes associations in the Middle East
  • Review of published articles and white papers on diabetes care devices and technology trends
  • Examination of government health statistics and diabetes prevalence data across the region

Primary Research

  • Interviews with healthcare professionals, including endocrinologists and diabetes educators
  • Surveys conducted with medical device distributors and suppliers in the diabetes care sector
  • Focus group discussions with patients using diabetes care devices to gather user experience insights

Validation & Triangulation

  • Cross-validation of findings through multiple data sources, including industry reports and expert opinions
  • Triangulation of market data with sales figures from leading diabetes device manufacturers
  • Sanity checks through expert panel reviews comprising healthcare professionals and market analysts

Phase 2: Market Size Estimation1

Top-down Assessment

  • Estimation of the total addressable market based on diabetes prevalence rates in the Middle East
  • Segmentation of the market by device type, including glucose monitors, insulin pumps, and continuous glucose monitoring systems
  • Incorporation of regional healthcare expenditure trends and government initiatives for diabetes management

Bottom-up Modeling

  • Collection of sales data from key diabetes care device manufacturers operating in the region
  • Estimation of market share based on unit sales and revenue figures from major distributors
  • Volume x price analysis to determine the overall market value for each device category

Forecasting & Scenario Analysis

  • Multi-factor regression analysis incorporating factors such as population growth, healthcare access, and technological advancements
  • Scenario modeling based on potential changes in healthcare policies and diabetes management practices
  • Development of baseline, optimistic, and pessimistic forecasts through 2030

Phase 3: CATI Sample Composition1

Scope Item/SegmentSample SizeTarget Respondent Profiles
Healthcare Professionals150Endocrinologists, Diabetes Educators
Medical Device Distributors100Sales Managers, Product Managers
Diabetes Patients200Type 1 and Type 2 Diabetes Patients
Healthcare Policy Makers80Health Ministry Officials, Public Health Experts
Market Analysts50Healthcare Market Analysts, Research Consultants

Frequently Asked Questions

What is the current value of the Middle East BRIC Diabetes Care Devices Market?

The Middle East BRIC Diabetes Care Devices Market is valued at approximately USD 2.5 billion. This valuation reflects the increasing prevalence of diabetes and the adoption of advanced technologies in diabetes management across the region.

What factors are driving the growth of the diabetes care devices market in the Middle East?

Which countries are the major players in the Middle East BRIC Diabetes Care Devices Market?

Who are the leading companies in the diabetes care devices market?

Why Buy From Us?

Refine Robust Result (RRR) Framework
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follow Robust, Refine and Result (RRR) methodology. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents' facts and opinions, and Result for presenting data with story.

Our Reach Is Unmatched
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Shifting the Research Paradigm
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

More Insights-Better Decisions
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Transparency and Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

Round the Clock Support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Clients Choose Us?

400000+
Reports in repository
150+
Consulting projects a year
100+
Analysts
8000+
Client Queries in 2022